“Sunshine” on Marketing, Research Payments Expands

In this ISSUE

Digital Talent & Real Estate

The Synergistic Organization: Global Capabilities, Local Leadership

Attacks on Pharmaceutical Improvement Patents

Top Story

"Sunshine" on Marketing, Research Payments Expands at Home and Abroad

As part of the legislation expanding the federal Open Payments program, drug and medical device manufacturers will have to report payments and other "transfers of value" to a broader range of health professionals
… /Read more/

Thought Leadership Series: Executive Search Tips
Watch Pharmaceutical Executive interview Jason Hersh of Klein Hersh about finding the best people for your organization.

Watch Videos
Sponsored by: Klein Hersh

Overview

Drug Pricing & Politics Roundup

Jill Wechsler casts her eye over the multitude of health reform measures emerging on Capitol Hill
… /Read more/

Calendar

/ September 10–11: 5^th Annual Bio/Pharmaceutical Product Launch Summit /

Cambridge, MA

/ September 12–13: 5^th Annual Compliance Congress for Specialty Products /

Cambridge, MA

/ September 18–19: 5^th Edition Drug Pricing Transparency Congress /

Philadelphia, PA.

/ September 24–25: 3^rd Annual Finance & Accounting for Bioscience Companies /

Cambridge, MA

/ October 8–9: Life Sciences West Coast Compliance Congress /

San Francisco, CA,

/ November 13–14: 6^th Annual Global Compliance Congress /

London, UK

/ December 11: eyeforpharma Awards 2019 /

Philadelphia, PA.

Pricing

Managing the 3 Fronts of the Drug Pricing Conundrum: Policy, Creativity, Collaboration

The impacts of disruptive curative therapies and advances in the future of health will be profound. To be best positioned for success, healthcare systems under continuous cost pressure must address three key areas, writes Thomas Unger
… /Read more/

Pricing

Congressional Pushback on Drug Pricing

Rick Kelly and Nisha Desai review the proposals in the Pharmaceutical Drug Pricing Reduction Act (PDPRA) with the greatest potential impact
… /Read More/

Opinion

When Accessing Healthcare Value is in the Eye of the Beholder

As patients pay more healthcare expenses directly from their own pockets, the industry must look at patients' ability to pay alongside willingness to pay to understand the various factors of patient decisions to accept or decline treatment, writes Joseph Saba
… /Read More/

Audio

Pharm Exec Podcast: Customer-Centric Innovation

Christine Sakdalan, Head of Franchise Strategy and Customer Solutions at Janssen Pharmaceutical, talks about how patient-centricity fuels innovation; the difference between patient and customer centricity; and educational programs that need to be implemented for patients, providers, and payers
… /Click here to listen/

Managing Global Regulatory Complexity: Clinical Trial Transparency, Reporting and Real-time Data Driven Compliance
On Demand

Learn more

Industry update

//Reata Pharmaceuticals (Irving, TX) appointed Manmeet S. Soni as Chief Financial Officer. Jason D. Wilson will assume a new role as EVP, Operations. // Orchestra BioMed (New Hope, PA) named Dennis Donohoe, M.D., as Chief Medical Officer. // Exactus (Delray Beach, FL) announced that Bobby Yampolsky will assume the duties of Interim Chairman and Emiliano Aloi, President, will assume the duties of Interim CEO while the company undertakes an executive search. // Cellectar Biosciences (Florham Park, NJ) announced the appointment of Mr. Dov Elefant as Chief Financial Officer, effective September 10, 2019. // Harvard Bioscience (Holliston, MA) appointed Michael Rossi as Chief Financial Officer. //

advertise with us / print subscribe / digital subscribe / visit pharmexec.com